Login / Signup

Nanomaterials with active targeting as advanced antimicrobials.

Kristyna SmerkovaKristyna DolezelikovaLucie BozdechovaZbynek HegerLudek ZurekVojtech Adam
Published in: Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology (2020)
With a growing health threat of bacterial resistance to antibiotics, the nanomaterials have been extensively studied as an alternative. It is assumed that antimicrobial nanomaterials can affect bacteria by several mechanisms simultaneously and thereby overcome antibiotic resistance. Another promising potential use is employing nanomaterials as nanocarriers for antibiotics in order to overcome bacterial defense mechanisms. The passive targeting of nanomaterials is the often used strategy for bacterial treatment, including intracellular infections of macrophages. Furthermore, the specific targeting enhances the efficacy of antimicrobials and reduces side effects. This review aims to discuss advantages, disadvantages, and challenges of nanomaterials in the context of the targeting strategies for antimicrobials as advanced tools for treatments of bacterial infections. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease.
Keyphrases
  • cancer therapy
  • drug discovery
  • healthcare
  • public health
  • staphylococcus aureus
  • mental health
  • multidrug resistant
  • risk assessment
  • human health